TRP Natural Eyes Allergy Relief Eye Drops Recalled for Sterility Assurance Issues
Optikem International is recalling TRP Natural Eyes Allergy Eyes Relief eye drops due to lack of assurance of sterility. The recall affects 30,240 bottles distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall of a sterile pharmaceutical product for lack of assurance of sterility. No illnesses or injuries have been reported, making this a theoretical risk-of-harm situation per the severity rubric.
Plain-English summary
TRP Natural Eyes Allergy Eyes Relief, a sterile eye drop product manufactured by Optikem International, Inc., is being recalled due to lack of assurance of sterility. The recalled product is a 0.33 FL OZ (10mL) homeopathic eye drop formulation distributed nationwide across the United States.
The recall affects three lot numbers: A703 (expiring 02-15-2026), A704 (expiring 03-22-2026), and A705 (expiring 04-05-2026). Approximately 30,240 bottles of the product have been distributed.
The FDA has classified this as a Class II recall. Consumers who have purchased this product should stop using it and contact their healthcare provider if they have experienced any adverse effects. Affected batches can be identified by the lot numbers listed above, and consumers are advised to check the packaging for these lot numbers.
The recalled product
- Product
- TRP Natural Eyes Allergy Eyes Relief, Sterile Eye Drops, Homeopathic 0.33 FL OZ (10mL), Manufactured for TRP Company, Inc, 1575 Delucchi Lane, Suite # 208, Reno, NV, NDC # 17312-032-15.
- Manufacturer
- Optikem International, Inc.
- Category
- Drug — Eye Drops / Ophthalmic
- Hazard
- lack-of-sterility
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #: A703
- Exp: 02-15-2026
- A704
- Exp: 03-22-2026
- A705
- Exp: 04-05-2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27